GLYX13

unnlisted · Naurex, Inc (affiliate of Allergan plc)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLYX13, covering 2019-11-27 to 2019-11-27. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Extension for GLYX13-C-202, NCT01684163 [Phase 2]